Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis

PURPOSE: Cardiotoxicity affects 5–16% of cancer patients who receive anthracyclines and/or trastuzumab. Limited research has examined interventions to mitigate cardiotoxicity. We examined the role of statins in mitigating cardiotoxicity by performing a systematic review and meta-analysis of publishe...

Descripción completa

Detalles Bibliográficos
Autores principales: Obasi, Mary, Abovich, Arielle, Vo, Jacqueline B., Gao, Yawen, Papatheodorou, Stefania I., Nohria, Anju, Asnani, Aarti, Partridge, Ann H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541988/
https://www.ncbi.nlm.nih.gov/pubmed/34406595
http://dx.doi.org/10.1007/s10552-021-01487-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541988/
https://www.ncbi.nlm.nih.gov/pubmed/34406595
http://dx.doi.org/10.1007/s10552-021-01487-1

Ejemplares similares